| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |